Your browser doesn't support javascript.
loading
To wean or not to wean: proton pump inhibitor management after anti-reflux surgery amongst foregut experts.
Pflüger, Michael Johannes; Coker, Alisa Mae; Zosa, Brenda Marie; Adrales, Gina Lynn; Parker, Brett Colton.
Afiliação
  • Pflüger MJ; Division of Minimally Invasive Surgery, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
  • Coker AM; Division of Minimally Invasive Surgery, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
  • Zosa BM; Division of Minimally Invasive Surgery, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
  • Adrales GL; Division of Minimally Invasive Surgery, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
  • Parker BC; Division of Minimally Invasive Surgery, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA. Bparke27@jh.edu.
Surg Endosc ; 38(7): 3992-3998, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38844731
ABSTRACT

BACKGROUND:

Most patients undergoing anti-reflux surgery (ARS) have a history of preoperative proton pump inhibitor (PPI) use. It is well-established that ARS is effective in restoring the anti-reflux barrier, eliminating the ongoing need for costly PPIs. Current literature lacks objective evidence supporting an optimal postoperative PPI cessation or weaning strategy, leading to wide practice variations. We sought to objectively gauge current practice and opinion surrounding the postoperative management of PPIs among expert foregut surgeons and gastroenterologists in the United States.

METHODS:

We created a survey of postoperative PPI management protocols, with an emphasis on discontinuation and timing of PPI cessation, and aimed to determine what factors played a role in the decision-making. An electronic survey tool (Qualtrics XM, Qualtrics, Provo, UT) was used to distribute the survey and to record the responses anonymously for a period of three months.

RESULTS:

The survey was viewed 2658 times by 373 institutions and shared with 644 members. In total, 121 respondents participated in the survey and 111 were surgeons (92%). Fifty respondents (42%) always discontinue PPIs immediately after ARS. Of the remaining 70 respondents (58%), 46% always wean or taper PPIs postoperatively and 47% wean or taper them selectively. The majority (92%) of practitioners taper within a 3-month period postoperatively. Five respondents never discontinue PPIs after ARS. Overall, only 23 respondents (19%) stated their protocol is based on medical literature or evidence-based medicine. Instead, decision-making is primarily based on anecdotal evidence/personal preference (42%, n = 50) or prior training/mentors (39%, n = 47).

CONCLUSIONS:

There are two major protocols used for PPI discontinuation after ARS Nearly half of providers abruptly stop PPIs, while just over half gradually tapers them, most often in the early postoperative period. These decisions are primarily driven by institutional practices and personal preferences, underscoring the need for evidence-based recommendations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Padrões de Prática Médica / Refluxo Gastroesofágico / Inibidores da Bomba de Prótons Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Surg Endosc Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Padrões de Prática Médica / Refluxo Gastroesofágico / Inibidores da Bomba de Prótons Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Surg Endosc Ano de publicação: 2024 Tipo de documento: Article